| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 73.3% | 22/30 |
| Female | 26.7% | 8/30 |
| Indifferent | 0% | 0/30 |
| Unknown | 0% | 0/30 |
| General | ||
| 20% | 6/30 | |
| 13.3% | 4/30 | |
| 6.7% | 2/30 | |
| 30% | 9/30 | |
| 24.1% | 7/29 | |
| 10% | 3/30 | |
| 26.7% | 8/30 | |
| 96.7% | 29/30 | |
| 86.7% | 26/30 | |
| 100% | 26/26 | |
| Neurology | ||
| 30% | 9/30 | |
| 63.3% | 19/30 | |
| 50% | 15/30 | |
| Facial abnormalities | ||
| 46.7% | 14/30 | |
| 63.3% | 19/30 | |
| 50% | 15/30 | |
| 60% | 18/30 | |
| Visual and hearing impairments | ||
| 30% | 9/30 | |
| 43.3% | 13/30 | |
| Heart | ||
| 33.3% | 10/30 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/27 |
| Gastrointestinal | ||
| 53.3% | 16/30 | |
| Urogenital | ||
| 16.7% | 5/30 | |
| Skeleton | ||
| 63.3% | 19/30 | |
| Skin / Hair / Nails | ||
| 66.7% | 20/30 | |
| Endocrine / Immunological / Metabolic | ||
| 3.3% | 1/30 | |
| 3.3% | 1/30 | |
| 53.3% | 16/30 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/30 |
| Inheritance | ||
| 6.7% | 2/30 | |
SMARCA4